Abstract
Background
Precision medicine (PM) is in great progressive stages in the West and allows healthcare practitioners (HCPs) to give treatment according to the patient’s genetic findings, physiological and environmental characteristics. PM is a relatively new treatment approach in Pakistan Therefore, it is important to investigate the level of awareness, attitude, and challenges faced by oncology physicians while practicing PM for various therapies, especially cancer treatment.
Objectives
The present study aims to explore the level of awareness, attitude, and practice of PM in Pakistan along with the challenges faced by the oncologists for the treatment of cancer using the PM approach.
Methods
Phenomenology-based qualitative approach was used. Face-to-face in-depth interviews were conducted using the purposive sampling approach among oncologists in Lahore, Pakistan. The data were analyzed using thematic content analysis to identify themes and sub-themes.
Results
Out of 14 physicians interviewed 11 were aware of PM. They were keen on training to hone their skills and agreed on providing PM. Oncologists believed PM was expensive and given to affluent patients only. Other impeding factors include cost, lack of knowledge, and drug unavailability.
Conclusions
Despite basic knowledge and will to practice, resource and cost constraints were marked as significant barriers. Additional training programs and inclusion into the curriculum may help to pave the way to PM implementation in the future. In addition, health authorities and policymakers need to ensure a cheaper PM treatment can be made available for all cancer patients.
Publisher
Public Library of Science (PLoS)
Reference45 articles.
1. Pagán CN: Precision Medicine: The Future of Health Care Is Now. https://www.webmd.com/cancer/features/precision-medicine-future#1%EE%80%83[Accessed%EE%80%83April%EE%80%8328,%EE%80%832019 (2019). Accessed 08-06-2019 2019.
2. Leja D: Biomarker Testing for Cancer Treatment. https://www.cancer.gov/about-cancer/treatment/types/biomarker-testing-cancer-treatment (2021). Accessed 24-03-2021
3. Healthcare Professionals’ Knowledge of Pharmacogenetics and Attitudes Towards Antimicrobial Utilization in Zambia: Implications for a Precision Medicine Approach to Reducing Antimicrobial Resistance.;W Mufwambi;Frontiers in Pharmacology,2021
4. Precision medicine: from science to value;GS Ginsburg;Health Affairs,2018
5. When personal feels invasive: Foreseeing challenges in precision medicine communication;CL Ratcliff;Journal of Health Communication,2018